Global Pharmaceuticals & Biotech Most Popular Stocks

Biofrontera

Market Cap: €16.2m

A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.

BriaCell Therapeutics

Market Cap: CA$26.3m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

May & Baker Nigeria

Market Cap: ₦27.9b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

SoftOx Solutions

Market Cap: NOK 187.2m

Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.

SenzaGen

Market Cap: SEK 176.4m

Provides non-animal tests for assessing allergenicity.

Noxopharm

Market Cap: AU$28.6m

A biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia.

Aspire Biopharma Holdings

Market Cap: US$18.7m

An early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States.

Alligator Bioscience

Market Cap: SEK 175.3m

A research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Finland and Sweden.

Zeo ScientifiX

Market Cap: US$18.6m

A clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines.

Poxel

Market Cap: €15.9m

A clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases.

Medivir

Market Cap: SEK 174.3m

A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.

Resverlogix

Market Cap: CA$25.8m

A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.

Cellectar Biosciences

Market Cap: US$18.4m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

Urteste

Market Cap: zł66.1m

Engages in the research and development of diagnostic tests for cancers.

Vectorite Biomedical

Market Cap: NT$551.5m

Engages in the research and development of biotechnology in Taiwan and internationally.

AcuCort

Market Cap: SEK 170.7m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

New Green Hemp

Market Cap: US$17.9m

New Green Hemp Inc. cultivates and sells hemp products.

Lactose (India)

Market Cap: ₹1.6b

Engages in the manufacture and trading of pharmaceutical products in India and internationally.

Biovica International

Market Cap: SEK 167.9m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

Neimeth International Pharmaceuticals

Market Cap: ₦26.5b

Manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana.

BioInfra

Market Cap: ₩25.1b

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials.

ProPhase Labs

Market Cap: US$17.8m

Develops and commercializes novel drugs, dietary supplements, and compounds in the United States.

Celemics

Market Cap: ₩24.9b

Designs, manufactures, and distributes sequencing kits in South Korea.

Telescope Innovations

Market Cap: CA$24.6m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

Greenway Greenhouse Cannabis

Market Cap: CA$24.5m

Engages in the cultivation, processing, sale, bulk package, and wholesale of dry bud cannabis.

Quest Laboratories

Market Cap: ₹1.6b

Manufactures and sells pharmaceutical formulations in India.

Aelis Farma

Market Cap: €15.0m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

IXICO

Market Cap: UK£13.0m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

Vaishali Pharma

Market Cap: ₹1.5b

Engages in the pharmaceutical business in India and internationally.

Krebs Biochemicals & Industries

Market Cap: ₹1.5b

Engages in the manufacture and sale of active pharmaceutical ingredients in India.

IDT Australia

Market Cap: AU$26.2m

Engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States.

Edesa Biotech

Market Cap: US$17.2m

A clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.

Invites Biocore

Market Cap: ₩24.2b

Provides bioanalytical and central lab services in South Korea and internationally.

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م825.3m

Develops, produces, and sells pharmaceutical products in Egypt.

Charlotte's Web Holdings

Market Cap: CA$23.9m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

Abpro Holdings

Market Cap: US$17.1m

A biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology.